Skip to main content
OpenTrials
Completed

NCT Number: NCT05817500

Post-ICU Consultation : a Time to Discuss Advance Directives (CoPRADA)

The aim of this study is to assess the possibility of discussing advance directives during post-intensive care consultation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Brest

Brest, 29200, France

About this study

After a stay in intensive care units (ICU), patients can experience physical, psychological and cognitive impairments. To assess this post intensive care syndrom (PICS), post-ICU consultation have been developed.

Since 5 year mortality is higher in ICU survivors, it might be interesting to address those patients' views relating to illness and end of life through a discussion on advance directives (AD), during post-ICU consultation.

However, the development of these consultations being recent, it has not yet been assessed whether this consultations might be a suitable time to discuss AD and the intensivit a suitable interlocutor.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with 48 hours of mechanical ventilation
  • Patients with a 5 days stay in ICU

Exclusion criteria

  • Patients with therapeutic limitation discussed during their ICU stay
  • Geographical remotness to come to the post-ICU consultation
  • Minor patients
  • Patient not affiliated to the social security scheme

Treatment and study plan

Primary outcomes

  1. Number of patients willing to discuss AD after an ICU stay

    Time frame: 1 year

    Number of patient willing to discussion AD after ICU stay will be observed

Secondary outcomes

  1. Number of patients knowing about AD before their ICU stay

    Time frame: 1 year

    Number of patient knowing before AD before ICU stay will be observed

  2. Factors influencing the writing of AD after an ICU stay

    Time frame: 1 year

    Factors such as lenght of stay in ICU, lenght of hospitalisation, duration of mechanical ventilation /sedation and the existence of PTSD (PCLS) or anxiety/ depression (HADS) will be evaluated and their influence on the completion of AD

  3. Evaluation of the privileged interlocutor to discuss AD

    Time frame: 1 year

    The privileged interlocutor to discuss AD will be observed

  4. Evaluation of the privileged interlocutor to complete AD

    Time frame: 1 year

    The privileged interlocutor to complete AD will be observed

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Post-ICU Consultation : a Time to Discuss Advance Directives

Acronym: CoPRADA

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Apr 18, 2023
Registry last updated
Apr 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.